Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ : 130.88 (+0.57%)
ZTS : 117.03 (-0.70%)
Here is Why Growth Investors Should Buy Jazz (JAZZ) Now

Jazz (JAZZ) possesses solid growth attributes, which could help it handily outperform the market.

JAZZ : 130.88 (+0.57%)
Bet on These 5 High Earnings Yield Stocks to Book Profits

Check out these five high earnings yield stocks for a powerful portfolio.

LAD : 161.39 (+1.13%)
KBH : 33.56 (+2.91%)
AXE : 85.14 (-0.19%)
NAVI : 14.52 (+1.54%)
JAZZ : 130.88 (+0.57%)
Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

JAZZ : 130.88 (+0.57%)
Jazz Pharmaceuticals to Highlight Growing Hematology Oncology Pipeline at ASH 2019 Annual Meeting

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 15 abstracts sponsored by Jazz Pharmaceuticals, including one oral presentation, one abstract from a collaboration trial with MD Anderson Cancer...

JAZZ : 130.88 (+0.57%)
Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales

Jazz Pharmaceuticals (JAZZ) beats third-quarter 2019 earnings and revenue estimates and raises its guidance for 2019.

IRWD : 11.11 (+0.82%)
DERM : 8.05 (-2.19%)
JAZZ : 130.88 (+0.57%)
FGEN : 35.40 (-14.94%)
Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Surpass Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of 14.21% and 2.87%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

JAZZ : 130.88 (+0.57%)
Jazz: 3Q Earnings Snapshot

DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported third-quarter earnings of $102.3 million.

JAZZ : 130.88 (+0.57%)
Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2019 and updated 2019 financial guidance.

JAZZ : 130.88 (+0.57%)
ImmunoGen (IMGN) Q3 Earnings & Sales Beat, Shares Rally

ImmunoGen (IMGN) reports narrower-than-expected third-quarter loss and beats revenue estimates. The company is set to initiate the FDA recommended phase III study on mirvetuximab soravtansine by year-end....

ABBV : 85.66 (+0.53%)
CELG : 109.57 (+0.03%)
JAZZ : 130.88 (+0.57%)
IMGN : 3.25 (-2.99%)
What's in the Cards for Teva (TEVA) This Earnings Season?

Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q3 sales

LLY : 112.80 (-0.64%)
AMGN : 220.70 (-0.19%)
JAZZ : 130.88 (+0.57%)
TEVA : 9.33 (+0.32%)
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More

Let us take a look at five drug/biotech companies, which are supposed to release their quarterly results on Nov 5.

AGN : 181.58 (+0.17%)
GSK : 44.26 (-0.36%)
REGN : 344.28 (+0.73%)
AMGN : 220.70 (-0.19%)
JAZZ : 130.88 (+0.57%)
CTLT : 49.85 (+0.67%)
MYL : 17.24 (-2.10%)
WIll Allergan (AGN) Beat Estimates This Earnings Season?

Allergan's (AGN) key products like Botox are likely to have provided top-line support in Q3 as loss of exclusivity of several products hurts sales.

AGN : 181.58 (+0.17%)
ABBV : 85.66 (+0.53%)
JAZZ : 130.88 (+0.57%)
PTLA : 28.05 (-1.41%)
Is a Beat in the Cards for Mallinckrodt (MNK) in Q3 Earnings?

Investors are looking forward to the performance of Specialty Brands and other pipeline updates, when Mallinckrodt (MNK) reports Q3 results.

AGN : 181.58 (+0.17%)
REGN : 344.28 (+0.73%)
JAZZ : 130.88 (+0.57%)
MNK : 2.86 (-8.04%)
Is a Beat in the Cards for Regeneron (REGN) Q3 Earnings?

Investors will focus on the performance of Eylea and Dupixent along with other pipeline updates, when Regeneron (REGN) reports third-quarter 2019 results.

AGN : 181.58 (+0.17%)
BAYRY : 19.4600 (-0.31%)
REGN : 344.28 (+0.73%)
JAZZ : 130.88 (+0.57%)
Bristol-Myers (BMY) Hits Fresh High: Is There Still Room to Run?

Bristol-Myers (BMY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

BMY : 58.15 (+0.22%)
ABBV : 85.66 (+0.53%)
GSK : 44.26 (-0.36%)
JAZZ : 130.88 (+0.57%)
Guardant Health (GH) to Report Q3 Earnings: What's in Store?

During Guardant Health's (GH) Q3 conference call, investors will watch out for the latest news on the colorectal cancer screening rates of its LUNAR-2 blood test.

ALNY : 92.45 (-0.62%)
JAZZ : 130.88 (+0.57%)
PTLA : 28.05 (-1.41%)
GH : 72.97 (+1.50%)
Small Step Back Ahead of Fed, Apple

Small Step Back Ahead of Fed, Apple

PODD : 173.99 (+2.67%)
LNG : 61.44 (-0.49%)
PCRX : 43.51 (-1.16%)
TSLA : 345.09 (+2.36%)
AMZN : 1,771.65 (-0.80%)
BIDU : 120.87 (-2.96%)
OXY : 38.88 (-3.04%)
PTC : 73.18 (-0.07%)
GRUB : 37.16 (+2.68%)
QUOT : 10.54 (+1.25%)
ERII : 9.28 (-1.90%)
JAZZ : 130.88 (+0.57%)
MTH : 69.10 (+2.04%)
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

Jazz (JAZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JAZZ : 130.88 (+0.57%)
Catalyst Pharma (CPRX) to Post Q3 Earnings: What's in Store?

During Catalyst's (CPRX) third-quarter 2019 conference call, investor focus will be on the sales performance of its only marketed drug Firdapse and its label expansion studies.

ALNY : 92.45 (-0.62%)
PTLA : 28.05 (-1.41%)
JAZZ : 130.88 (+0.57%)
CPRX : 5.02 (-0.99%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.30 , AIZ -0.99 , SBAC +0.16 , SO -0.79 , WELL +0.23
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar